IODINE clinical trials

A phase I/II randomized, assessor-blind, vehicle-controlled study to assess the safety, tolerability, and pharmacodynamics of DLQ03 in a wound healing model in patients with mild to moderate atopic dermatitis that are colonized with S. Aureus

This study is testing a new treatment, DLQ03, for eczema. It's for adults with mild to moderate eczema that also has a common skin germ called S. Aureus. The study will check if DLQ03 is safe and how well it works.